Harald Reinhart - 16 Jun 2021 Form 4 Insider Report for Zai Lab Ltd (ZLAB)

Role
Chief Medical Officer
Signature
/s/ Bruce A. Blefeld, Attorney-in-Fact
Issuer symbol
ZLAB
Transactions as of
16 Jun 2021
Net transactions value
-$2,283,600
Form type
4
Filing time
17 Jun 2021, 20:04:48 UTC
Previous filing
26 May 2021
Next filing
15 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZLAB Ordinary Shares Options Exercise $167,200 +8,000 $20.90 8,000 16 Jun 2021 Direct F1
transaction ZLAB Ordinary Shares Sale $1,301,680 -8,000 -100% $162.71* 0 16 Jun 2021 Direct F1
transaction ZLAB Ordinary Shares Options Exercise $144,000 +8,000 $18.00 8,000 17 Jun 2021 Direct F1
transaction ZLAB Ordinary Shares Sale $1,293,120 -8,000 -100% $161.64* 0 17 Jun 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZLAB Stock Options (Right to Buy) Options Exercise $0 -8,000 -12% $0.000000 60,000 16 Jun 2021 Ordinary Shares 8,000 $20.90 Direct F1, F2
transaction ZLAB Stock Options (Right to Buy) Options Exercise $0 -8,000 -13% $0.000000 52,000 17 Jun 2021 Ordinary Shares 8,000 $18.00 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 17, 2021, expires August 30, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
F2 The options vest in equal annual installments over five years beginning on 03/28/2019, the first anniversary of the date of grant.
F3 The options vest in equal annual installments over five years beginning on 09/20/2018, the first anniversary of the date of grant.